Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Tapson

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
TH Open : Companion Journal to Thrombosis and Haemostasis|December 10, 2019
Intermediate-High Risk Pulmonary EmbolismRosa Mirambeaux, Francisco León, Behnood Bikdeli, et al.
Current Medical Research and Opinion|May 26, 2021
Immune-mediated diseases and thromboembolic events: a modified Delphi panelNassir Azimi, Freddy Caldera, Stan Cohen, et al.
Plos One|November 7, 2017
Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolismDeisy Barrios, Raquel Morillo, Ina Guerassimova, et al.
Chest|September 3, 2021
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary EmbolismAna Jaureguízar, David Jiménez, Behnood Bikdeli, et al.
Thorax|November 15, 2017
Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysisDavid Jimenez, Carlos Martin-Saborido, Alfonso Muriel, et al.
Journal of Thrombosis and Thrombolysis|March 2, 2011
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocolAlexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, et al.
The European Respiratory Journal|May 5, 2018
Management appropriateness and outcomes of patients with acute pulmonary embolismDavid Jiménez, Behnood Bikdeli, Deisy Barrios, et al.
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
American Heart Journal|September 20, 2015
Use of outcome measures in pulmonary hypertension clinical trialsKishan S Parikh, Sudarshan Rajagopal, Kristine Arges, et al.
JAMA Network Open|August 27, 2020
Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsGeoffrey D Barnes, Alona Muzikansky, Scott Cameron, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
TH Open : Companion Journal to Thrombosis and Haemostasis|December 10, 2019
Intermediate-High Risk Pulmonary EmbolismRosa Mirambeaux, Francisco León, Behnood Bikdeli, et al.
Current Medical Research and Opinion|May 26, 2021
Immune-mediated diseases and thromboembolic events: a modified Delphi panelNassir Azimi, Freddy Caldera, Stan Cohen, et al.
Plos One|November 7, 2017
Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolismDeisy Barrios, Raquel Morillo, Ina Guerassimova, et al.
Chest|September 3, 2021
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary EmbolismAna Jaureguízar, David Jiménez, Behnood Bikdeli, et al.
Thorax|November 15, 2017
Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysisDavid Jimenez, Carlos Martin-Saborido, Alfonso Muriel, et al.
Journal of Thrombosis and Thrombolysis|March 2, 2011
Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocolAlexander Thomas Cohen, Theodore Erich Spiro, Harry Roger Büller, et al.
The European Respiratory Journal|May 5, 2018
Management appropriateness and outcomes of patients with acute pulmonary embolismDavid Jiménez, Behnood Bikdeli, Deisy Barrios, et al.
The New England Journal of Medicine|February 8, 2013
Rivaroxaban for thromboprophylaxis in acutely ill medical patientsAlexander T Cohen, Theodore E Spiro, Harry R Büller, et al.
American Heart Journal|September 20, 2015
Use of outcome measures in pulmonary hypertension clinical trialsKishan S Parikh, Sudarshan Rajagopal, Kristine Arges, et al.
JAMA Network Open|August 27, 2020
Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response TeamsGeoffrey D Barnes, Alona Muzikansky, Scott Cameron, et al.
Pageof 5